Viatris (VTRS) Delivers Solid 2025 Growth and Robust Cash Flow at Deep Value [Yahoo! Finance]
Viatris Inc. (VTRS)
Company Research
Source: Yahoo! Finance
Viatris Inc. (NASDAQ: VTRS ) is one of the dirt cheap stocks to buy now . On February 26, Viatris reported a steady financial performance for the full-year 2025, generating $14.3 billion in total revenue, a 2% increase over the previous year when excluding Indore-related impacts. The company achieved an adjusted EBITDA of $4.2 billion and an adjusted EPS of $2.35, supported by $2.2 billion in free cash flow. The company's initiatives were marked by significant regulatory progress, including five positive Phase III readouts and the completion of 60 regional transactions, such as the acquisition of Aculys Pharma in Japan. For 2026, Viatris anticipates total revenue and adjusted EBITDA growth of approximately 2%, with new product revenue expected to contribute between $450 million and $550 million. Viatris (VTRS) Delivers Solid 2025 Growth and Robust Cash Flow at Deep Value Pixabay/Public Domain To support long-term competitiveness, a strategic review identified $650 million in
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- UBS and BofA Lift Price Targets on Viatris (VTRS) [Yahoo! Finance]Yahoo! Finance
- Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research [Yahoo! Finance]Yahoo! Finance
- GoodRx to offer up to 85% discount on Viatris drugs [Seeking Alpha]Seeking Alpha
- Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings? [Yahoo! Finance]Yahoo! Finance
- UBS Raises Viatris (VTRS) Price Target as Cost Savings and Growth Outlook Improve [Yahoo! Finance]Yahoo! Finance
VTRS
Earnings
- 2/26/26 - Beat
VTRS
Sec Filings
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- 3/10/26 - Form 4
- VTRS's page on the SEC website